The enteral feeding devices market has been witnessing significant growth over the past few years, driven by an increase in chronic diseases, advancements in medical technology, and a growing elderly population. Enteral feeding devices are medical devices used to deliver nutrition directly to the stomach or intestines, providing essential nutrients to patients who cannot consume food orally. This article delves into the market size and application of enteral feeding devices, focusing on four key medical areas: oncology, gastrointestinal disorders, neurological disorders, and diabetes.
Enteral Feeding Devices Market Size by Application (Oncology, Gastrointestinal, & Neurological Disorders, Diabetes) – Global Forecast to 2029
Enteral feeding devices market in terms of revenue was estimated to be worth $4.0 billion in 2023 and is poised to reach $5.6 billion by 2029, growing at a CAGR of 6.2%
Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183623035
Market Overview
The global enteral feeding devices market is poised for substantial growth, with a projected compound annual growth rate (CAGR) of approximately 6.2% over the next decade. This growth is attributed to the rising prevalence of chronic diseases, increasing awareness about enteral nutrition, and technological advancements in feeding devices. The market encompasses a range of products, including enteral feeding pumps, tubes, administration sets, and other accessories.
Oncology
Market Size and Growth Drivers
Oncology represents one of the largest segments in the enteral feeding devices market. Cancer patients, particularly those with head, neck, esophageal, and stomach cancers, often require enteral feeding due to difficulties in swallowing and maintaining adequate nutrition. The rising incidence of cancer globally has significantly contributed to the demand for enteral feeding devices.
According to the World Health Organization (WHO), the global cancer burden is expected to rise by 70% over the next two decades. This alarming increase is driving the demand for effective nutritional support systems, thereby boosting the enteral feeding devices market. Additionally, advancements in enteral feeding techniques and the development of more patient-friendly devices are expected to further stimulate market growth.
Application in Oncology
In oncology, enteral feeding devices are crucial for maintaining the nutritional status of patients undergoing chemotherapy, radiation, or surgery. These treatments can cause severe side effects, including mucositis, nausea, and vomiting, which impede oral intake. Enteral nutrition helps in preserving muscle mass, improving treatment tolerance, and enhancing overall quality of life.
Gastrointestinal Disorders
Market Size and Growth Drivers
The gastrointestinal (GI) disorders segment is another significant contributor to the enteral feeding devices market. Conditions such as Crohn’s disease, ulcerative colitis, short bowel syndrome, and severe pancreatitis often necessitate enteral nutrition. The increasing prevalence of GI disorders globally has spurred the adoption of enteral feeding solutions.
According to the American Gastroenterological Association, over 60-70 million people in the United States suffer from digestive diseases, creating a substantial demand for enteral feeding devices. The growing awareness about the benefits of early nutritional intervention in GI disorders is further propelling market growth.
Application in Gastrointestinal Disorders
For patients with GI disorders, enteral feeding ensures that they receive the necessary nutrients while reducing the workload on the gastrointestinal tract. Enteral feeding devices are used for both short-term and long-term nutritional support, depending on the severity and nature of the condition. These devices help in managing symptoms, preventing malnutrition, and promoting faster recovery.
Neurological Disorders
Market Size and Growth Drivers
Neurological disorders, including stroke, multiple sclerosis, Parkinson’s disease, and traumatic brain injuries, significantly impact patients’ ability to consume food orally. The enteral feeding devices market within this segment is growing due to the increasing incidence of neurological conditions and the need for long-term nutritional support.
The World Health Organization (WHO) reports that neurological disorders are the leading cause of disability-adjusted life years (DALYs) and the second leading cause of deaths worldwide. This underscores the critical need for effective nutritional management in these patients, driving the demand for enteral feeding devices.
Application in Neurological Disorders
Enteral feeding devices are essential for patients with neurological disorders who experience dysphagia (difficulty swallowing) or other complications affecting oral intake. These devices ensure that patients receive adequate nutrition to support their overall health and recovery. Enteral nutrition can help prevent malnutrition, reduce the risk of aspiration pneumonia, and improve neurological outcomes.
Diabetes
Market Size and Growth Drivers
Diabetes is a growing global health concern, with millions of individuals diagnosed with the condition each year. Enteral feeding devices play a crucial role in managing diabetes, particularly in patients with severe complications such as diabetic gastroparesis or those undergoing major surgeries.
According to the International Diabetes Federation (IDF), approximately 463 million adults were living with diabetes in 2019, and this number is expected to rise to 700 million by 2045. This significant increase in the diabetic population is driving the demand for enteral feeding solutions that can help manage nutritional needs effectively.
Application in Diabetes
In diabetic patients, enteral feeding devices are used to deliver precise and controlled nutrition, which is essential for managing blood glucose levels and preventing complications. Enteral nutrition is particularly beneficial for diabetic patients who have difficulty maintaining adequate oral intake due to complications such as gastroparesis, a condition that slows or stops the movement of food from the stomach to the small intestine.
Conclusion
The enteral feeding devices market is expanding rapidly, driven by the increasing prevalence of chronic diseases, advancements in medical technology, and a growing awareness of the benefits of enteral nutrition. The market’s growth is particularly pronounced in the fields of oncology, gastrointestinal disorders, neurological disorders, and diabetes. As the global healthcare landscape continues to evolve, the demand for enteral feeding devices is expected to rise, offering significant opportunities for innovation and development in this vital area of medical care.
